HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon Returns To Salon Channel With $660 Mil. Colomer Acquisition

This article was originally published in The Rose Sheet

Executive Summary

Thirteen years after selling its professional products business to CVC Capital Partners, Revlon buys it back, now in a position to grow the salon hair- and nail-care brands. The acquisition extends the firm’s reach in markets outside of the U.S. and, according to Kline’s Carrie Mellage, “signals Revlon’s return as a serious contender in the personal-care industry.”

You may also be interested in...



In Brief: Anti-Aging Bleach? Kline On Pro Skin Care; PCPC’s Microbiology Guide

Mice bathed in a dilute bleach solution exhibited younger-looking skin in a recently published study, but The Clorox Company advises consumers to use its products only as directed. More news in brief.

In Brief: China Lightens Animal-Test Requirements; Coty In UAE; Eyeliner Recall; More

Foreign manufacturers may be able to market cosmetics in China without animal testing by partnering with a domestic toll manufacturer under changes to Chinese regulations announced in late December. More news in brief.

Sales & Earnings In Brief

Sales advanced 5% to $2.7 billion at Estee Lauder in the first fiscal quarter; Revlon posts Q3 profit and adds new CEO. More sales and earnings news in brief.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel